@Sambong @nadaladawada Those of us invested in TRVN would freakin' love to hear that we've partnered with Merck for distribution. But I doubt there's anything tomorrow or on 11th that wasn't included in the published update this week. IF there's an update on the 027 trial in London, that could spike the price, which would be "lovely," as the Brits say. But I'm not holding my breath.